Targeting the gut–lung microbiota axis by means of a high-fibre diet and probiotics may have anti-inflammatory effects in COVID-19 infection

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) 1 is a 2019 novel coronavirus, which only in the European area has led to more than 300,000 cases with at least 21,000 deaths. This manuscript aims to speculate that the manipulation of the microbial patterns through the use of probiotics...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Therapeutic advances in respiratory disease 2020, Vol.14, p.1753466620937170-1753466620937170
Hauptverfasser:	Conte, Luana, Toraldo, Domenico Maurizio
Format:	Artikel
Sprache:	eng
Schlagworte:	Betacoronavirus - isolation & purification Coronavirus Infections - diet therapy Coronavirus Infections - epidemiology Coronavirus Infections - physiopathology Coronaviruses COVID-19 Diet Dietary Fiber - administration & dosage Gastrointestinal Microbiome Humans Immune System - virology Inflammation - pathology Inflammation - virology Letter to the Editor Lung - virology Pandemics Pneumonia, Viral - diet therapy Pneumonia, Viral - epidemiology Pneumonia, Viral - physiopathology Probiotics Probiotics - administration & dosage SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) 1 is a 2019 novel coronavirus, which only in the European area has led to more than 300,000 cases with at least 21,000 deaths. This manuscript aims to speculate that the manipulation of the microbial patterns through the use of probiotics and dietary fibers consumption may contribute to reduce inflammation and strengthen the immune system response in COVID-19 infection. The reviews of this paper are available via the supplemental material section.
ISSN:	1753-4666 1753-4658 1753-4666
DOI:	10.1177/1753466620937170